Aggrephagy: Selective Disposal of Protein Aggregates by Macroautophagy by Lamark, Trond & Johansen, Terje
Hindawi Publishing Corporation
International Journal of Cell Biology
Volume 2012, Article ID 736905, 21 pages
doi:10.1155/2012/736905
Review Article
Aggrephagy:SelectiveDisposal of
ProteinAggregates byMacroautophagy
Trond LamarkandTerje Johansen
Molecular Cancer Research Group, Institute of Medical Biology, University of Tromsø, 9037 Tromsø, Norway
Correspondence should be addressed to Terje Johansen, terje.johansen@uit.no
Received 1 December 2011; Accepted 6 January 2012
Academic Editor: Masaaki Komatsu
Copyright © 2012 T. Lamark and T. Johansen. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
Protein aggregation is a continuous process in our cells. Some proteins aggregate in a regulated manner required for diﬀerent vital
functional processes in the cells whereas other protein aggregates result from misfolding caused by various stressors. The decision
to form an aggregate is largely made by chaperones and chaperone-assisted proteins. Proteins that are damaged beyond repair
are degraded either by the proteasome or by the lysosome via autophagy. The aggregates can be degraded by the proteasome and
by chaperone-mediated autophagy only after dissolution into soluble single peptide species. Hence, protein aggregates as such
are degraded by macroautophagy. The selective degradation of protein aggregates by macroautophagy is called aggrephagy. Here
we review the processes of aggregate formation, recognition, transport, and sequestration into autophagosomes by autophagy
receptors and the role of aggrephagy in diﬀerent protein aggregation diseases.
1.Introduction
Misfolded proteins result from mutations, incomplete trans-
lation giving defective ribosomal products (DRiPs), mis-
folding after translation, aberrant protein modiﬁcations,
oxidative damage, and from failed assembly of protein com-
plexes. Misfolded proteins expose hydrophobic patches that
are normally buried internally in the native folded state.
These hydrophobic surfaces trigger aggregation and can
sequester normal proteins compromising their functionality
[1]. To defend cells against the hazards caused by accu-
mulation of misfolded proteins, diﬀerent protein quality
control machineries are active at several levels. Molecular
chaperones, like the heat shock proteins (Hsp), recognize,
assist folding, prevent aggregation, and attempt to repair
misfolded proteins. However, if the damage is beyond repair,
chaperone complexes, often in conjunction with interacting
ubiquitinE3ligases,channelthemisfoldedproteinorprotein
aggregates to degradation pathways.
1.1. The UPS. The two major degradation systems in the
cell are the ubiquitin-proteasome system (UPS) and the
lysosome (Figure 1). The UPS comprises the proteasome
and the enzymatic cascade catalysing the ubiquitination of
substrates destined for degradation in the proteasome. The
prime tag for proteasomal degradation is a chain of 4 or
moreubiquitinmoietiescovalentlylinkedtolysineresidue(s)
of the target. Ubiquitin has 7 internal lysines (K6, K11,
K27, K29, K33, K48, and K63) that can be linked, forming
polyubiquitin chains [2, 3]. K48-linked polyubiquitin chains
represent the canonical proteasomal degradation tag, but
also K11-linkages are used and some substrates with K63-
linked polyubiquitin can be degraded by the proteasome [4].
An enzyme cascade of E1 activation, E2 conjugation, and
E3 ligation enzymes mediates the ubiquitination of target
proteins[5].Thehumanrepertoireconsistsoftwoubiquitin-
speciﬁc E1 activation enzymes, about 30 E2 conjugation
enzymes, and more than 1000 E3 ligases providing a great
versatility in substrate recognition and enabling diversity in
ubiquitin chain linkages added to substrates [6–9].
The proteasome consists of a barrel-shaped catalytic
core particle, called the 20S proteasome, and the regulatory
particle [10, 11]. The cylindrical catalytic particle has a
central channel with a diameter of only ∼1.5nm with three
proteolytically active proteasomal subunits facing the inside
of this channel. Hence, the digestion chamber is inaccessible2 International Journal of Cell Biology
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Figure 1: Proteins recognized as misfolded by molecular chaperones can be degraded by selective autophagy, the ubiquitin-proteasome
system (UPS) or chaperone-mediated autophagy (CMA). In selective autophagy, misfolded proteins are often assembled into aggregates
beforetheyaredegraded.Theyarealsooftenubiquitinated,andthisinducestherecruitmentofubiquitinbindingcargoreceptorssuchasp62
and NBR1. These cargo receptors bind to ubiquitinated cargos (in this case a protein aggregate) and to ATG8 homologues conjugated to the
innersurfaceofthephagophore(LC3indicatedasbluedots).Thisway,cargosareselectivelydeliveredtotheinnersurfaceofthephagophore.
An autophagosome is formed by closure of the phagophore. The autophagosome fuses with a late endosome or with a lysosome, but the
end point is in both cases the formation of an autolysosome where the contents are degraded. Substrates for the UPS and CMA degradation
pathways need to be in a soluble and monomeric form. Degradation by the UPS depends on K48-linked polyubiquitination of the misfolded
substrate. The substrate is then delivered to the 26S proteasome, where it is deubiquitinated and degraded. Degradation by CMA depends
on an Hsc70-mediated recognition of a KFERQ motif on the misfolded substrate. The substrate is then delivered to the lysosomal receptor
LAMP-2A, transported into the lumen of the lysosome, and degraded.
for folded proteins. Substrate access is regulated by “gates”
on both sides of the 20S proteasome. The complete 26S
proteasome contains two 19S regulatory subunits, one on
each side, mediating substrate recognition, unfolding, and
transfer into the catalytic chamber of the 20S proteasome
[10–12]. The 19S regulatory particle consists of the base
and the lid. The base has six AAA-type ATPases (Rpt1–
Rpt6) forming the hexameric ring and four non-ATPase
subunits (Rpn1, Rpn2, Rpn10, and Rpn13). The hexameric
ringunfoldsproteasomalsubstratesandtogetherwithRpn1-
Rpn2 helps open the gate into the catalytic chamber of
the 20S proteasome. Rpn10 and Rpn13 recognize and
recruit proteasomal substrates by binding to the K48-linked
polyubiquitin degradation tag [13]. The lid has nine Rpn
subunits (Rpn3, Rpn5–9, Rpn11-12, and Rpn15). Rpn11 is
a de-ubiquitination enzyme (DUB) responsible for recycling
of ubiquitin [10, 11, 13].
1.2. Autophagy. The lysosomal degradation of intracellular
contents, such as misfolded proteins, protein aggregates,International Journal of Cell Biology 3
and organelles, is mediated by autophagy [14, 15]. Three
major types of autophagy have been described in mam-
malian cells, that is, macroautophagy [14–16], microau-
tophagy [17], and chaperone-mediated autophagy (CMA)
[18, 19]. Of these, macroautophagy (hereafter referred to
as autophagy) is the only process that can mediate the
degradation of larger substratessuch as organelles,microbes,
and protein aggregates (Figure 1). The UPS and CMA are
only capable of degrading one extended polypeptide at
the time. Autophagy is initiated by the formation of a
double-membrane structure, the phagophore. The source
of the phagophore membrane is still under debate, and
both the ER, mitochondria, plasma membrane, and the
Golgi apparatus have been implicated [20]. Elongation of
the phagophore depends on two ubiquitin-like conjugation
reactions. First, autophagy-related gene 12 (ATG12) is con-
jugated to ATG5 resulting in the formation of an oligomeric
ATG5-ATG12-ATG16L complex. This complex is then
needed for the conjugation of ATG8 homologues to phos-
phatidylethanolamine (PE) on the phagophore membrane
[21]. Mammalian ATG8 homologues are grouped into three
subfamilies, that is, the LC3 subfamily (LC3A, B, and C), the
GABARAPsubfamily(GABARAPandGABARAPL1/GEC1),
and GABARAPL2/GATE-16 [22]. Conjugation of ATG8
homologues to both sides of the phagophore enables them to
act as surface receptors for the speciﬁc recruitment of other
proteins. Lipidated ATG8 proteins are also involved in mem-
brane biogenesis of autophagosomes via their membrane
fusion activity [23]. Autophagosomes are formed by closure
of the phagophore into a double-membrane vesicle. Lipi-
datedATG8homologuesontheoutermembranearereleased
by ATG4B upon completion of autophagosome formation
[24]. In mammalian cells autophagosomes often form at the
cell periphery and are transported along microtubules and
fuse with late endosomes or lysosomes at the microtubule-
organizing centre (MTOC) area of the cells ﬁnally resulting
in degradation of their contents.
1.3. Selective Autophagy. Autophagy has been considered
as a bulk degradation system with little or no selectivity
that is induced to replenish energy stores upon starvation.
However, there is now considerable evidence to support
the notion that the process may also be highly speciﬁc
[25–27]. The term selective autophagy refers to the selec-
tive degradation of organelles, bacteria, ribosomes, speciﬁc
proteins, and protein aggregates by autophagy. In selective
autophagy, an important role is played by proteins acting as
autophagyreceptorssuchasp62andNBR1thatbinddirectly
to ATG8 homologues (Figure 1). The autophagy receptors
are themselves degraded by autophagy, and they mediate
selective autophagy via interactions with substrates that are
simultaneously degraded [26, 28–31]. Selective autophagy is
an important quality control system and is part of a basal
constitutive autophagy that can also be induced or boosted
by various stressors including oxidative stress, infections,
protein aggregation, and proteasomal inhibition [26, 32].
The formation of larger protein aggregates is regarded as
a cellular defense mechanism [33, 34]. The large aggregates
or inclusions are less toxic to the cell than the presence of
smaller microaggregates dispersed throughout the cell [33,
35–38].Sincethelargeinclusionsareusuallyreadilyvisiblein
the light microscope, while the more toxic soluble species are
not, the inclusions can also be used to distinguish between
diﬀerent neurodegenerative disorders involving aggregation
of speciﬁc, often mutant, proteins. The protein aggregates
may also represent intermediates in autophagic degrada-
tion of aggregation-prone proteins [39]. The assembly of
autophagy substrates into larger aggregates or clustered
structures is a common feature of selective autophagy [26].
It may facilitate their uptake into autophagosomes, and
aggregates may work as nucleation sites for the phagophore,
the forming isolation membrane [40].
Proteins damaged beyond repair are recognized and
sortedbychaperoneandco-chaperonecomplexescontaining
chaperone-assisted ubiquitin E3 ligases to three diﬀerent
degradation pathways: the UPS, CMA, and/or aggrephagy.
The term aggrephagy was introduced by Per Seglen to
describe the selective sequestration of protein aggregates by
autophagy [41]. In the following we will review the current
knowledge on how protein aggregates are recognized, sorted,
and degraded by aggrephagy.
2. CrosstalkbetweenDegradationPathways:
Hsp70/Hsp90 and Co-Chaperones
2.1. Quality Control of Newly Synthesized Proteins. Ac o m -
plex consisting of Hsp70, Hsp40, and several co-chaperones
including Cdc37 mediates the protein quality control of
newly synthesized proteins in the cytosol (Figure 2(a)).
In this process, DRiPs and aggregation-prone translational
products are degraded. Functional products are released
or delivered to the Hsp90 chaperone complex. In ER and
mitochondria, homologs of Hsp70 play a similar role in the
quality control of newly synthesized proteins. The protein
quality control in ER (reviewed in [42]) begins when a
nascent chain enters ER through the translocon. Newly
synthesized proteins transiently undergo cycling with the
ER luminal Hsp70 paralog BiP/GRP78 which is associated
with several co-chaperones. Proteins that are recognized
as misfolded or not properly processed are delivered for
ER-associated degradation (ERAD). ERAD substrates are
retranslocated into the cytoplasm where they are degraded
mainly by the UPS (Figure 3(a)). A chaperone holdase
activity mediated by an associated BAG6 complex is needed
to keep ERAD substrates unfolded, yet soluble, until they are
degraded [43].
2.2. Selective Degradation of Damaged Proteins. Quality
control of mature proteins is another important role of
Hsp70/Hsp90 chaperone complexes (Figure 2(a)). There is
considerablecrosstalkbetweentheHsp70andHsp90chaper-
one complexes, but in general Hsp90 protects proteins from
unfolding and aggregation, whereas Hsp70 is responsible for
their degradation in cases when unfolding or aggregation
cannotbeprevented.TheclassicclientsofHsp90areunstable
proteins that undergo tight cycling with the chaperone, and
in response to Hsp90 inhibition, these proteins are rapidly
deliveredtoHsp70anddegraded.Othermorestableproteins4 International Journal of Cell Biology
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Figure 2: Protein degradation assisted by heat shock proteins and their co-chaperones. (a) Substrates selected for degradation by heat
shock proteins are either defective ribosomal products (DRiPs) or Hsp90 client proteins that start to unfold or aggregate. Formation of the
latter type of substrate is increased under conditions of oxidative stress or during aging. (b) Misfolded and monomeric substrates bound
to Hsp70/Hsc70 are preferentially degraded by CMA or by the UPS. (c) In response to aggregation, or if the capacity of CMA and the
UPS is insuﬃcient, substrates are degraded by chaperone-assisted selective autophagy (CASA). This process relies on the co-chaperones
BAG3 and HspB8, the E3 ubiquitin ligase CHIP, and autophagy receptors such as p62. The process may also rely on the assembly of the
misfolded substrates into p62 bodies. (d) If degradation of misfolded substrates is impaired, BAG3 interacts with dynein and transport
protein aggregates along microtubules to the aggresome. The contents of aggresomes may subsequently be degraded by aggrephagy.
may be less dependent on Hsp90, but they may still undergo
dynamic cycling with the chaperone complex [44].
If a misfolded protein cannot be refolded by chaperones,
this normally results in its degradation by the UPS, CMA,
and/or selective autophagy. Since Hsp70 can mediate the
deliverytoallthreedegradationpathways,thesamesubstrate
can in principle be degraded by all three systems (Figures
2(b) and 2(c)). Ineﬃcient degradation by one system is often
compensated by increased degradation by another system.
Impairment of the UPS or CMA leads to activation of
autophagy [45–49]. Vice versa, in cells where autophagy is
inhibited, CMA is increased to compensate [50].
Previously, autophagy was considered to act only as a
back-up system when the capacity of UPS and CMA is
overwhelmed. However, selective autophagy is active also
undernormalconditions,andtissuessuchasbrain,liver,and
muscle have a constitutive need for selective autophagy [51–
55]. An obvious role for selective autophagy under normal
conditions is to degrade substrates that are not solubilized or
unfolded and exist as some form of aggregated structure.
2.3.DegradationbyCMAortheUPS. InCMA,cytosolicsub-
strates with a KFERQ-like motif are degraded in lysosomes
without the formation of autophagic vesicles (Figure 1).
Substrates are recognized by an Hsc70 complex, delivered
to the lysosomal receptor LAMP-2A, and transported into
the lumen of the lysosome where they are degraded [18,
19]. The KFERQ-like motif is present in 30% of cytosolic
proteins, and the fraction may be higher than this due
to posttranslational modiﬁcation [56]. CMA activity is
proportional to the level of LAMP-2A at the lysosomal
membrane. Expression of LAMP-2A is upregulated, and
CMA therefore increased under oxidative stress conditions
[57].
In order to be degraded by the UPS, a substrate must
be polyubiquitinated with chains consisting of four or more
preferably K48-linked ubiquitin moieties. CHIP (carboxyl
terminus of constitutive Hsc70-interacting protein) is a
cofactor for Hsp70 and Hsp90 and a prototype of the
chaperone-dependent ubiquitin E3 ligases involved in pro-
teasomal degradation of Hsp90 client proteins [58–60]. The
DUB ataxin-3 regulates the length of ubiquitin chains added
to CHIP substrates, and it is likely that this ubiquitination
is not only regulated by CHIP but also by other chaperone-
assisted E3 ligases and DUBs [61].
2.4. Chaperone-Assisted Selective Autophagy (CASA). The
group of Hohfeld has introduced the term chaperone-
assisted selective autophagy (CASA) to describe selectiveInternational Journal of Cell Biology 5
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Figure 3: Protein degradation assisted by p97/VCP and HDAC6. (a) Misfolded substrates located in the ER lumen or at the ER membrane
arerecognizedbytheERluminalHsp70homologueBiP/Grp78anddegradedbyER-associateddegradation(ERAD).Acomplexofp97/VCP
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cytoplasm, where they are degraded by the UPS. (c) p97/VCP mediates the segregation of selected substrates from nuclear or cytoplasmic
protein complexes, followed by their degradation by the UPS. (d) p97/VCP is also required for the transport of protein aggregates to the
aggresome. This depends on ubiquitination of the aggregate by an E3 ligase such as Parkin, and the delivery of the ubiquitinated aggregate
to HDAC6. HDAC6 binds to K63-linked polyubiquitin chains and to dynein, and it is responsible for the transport of ubiquitinated protein
aggregates along microtubules to the aggresome. The contents of aggresomes may subsequently be degraded by aggrephagy.
autophagy of misfolded proteins following a chaperone-
mediated formation of protein aggregates that are targeted
to form autophagosomes [62]. The dedicated chaperone
in CASA is BAG3 (Figure 2(c)). The BAG (Bcl2-associated
athanogene) family (BAG1-6) of co-chaperones uses their
BAG domain to interact with the ATPase domain of Hsp70.
BAG1 competes with Hip for interaction with Hsp70, and
binding of BAG1 induces proteasomal degradation of mis-
folded Hsp70 substrates (Figure 2(b)). Alternatively, a multi-
chaperone complex of Hsp70, BAG3, and HspB8 induces
selective degradation of misfolded proteins by autophagy.
Substrates shown to be degraded by this complex include
polyQ-expanded huntingtin [63] and SOD1 [64]. CASA is
important also under normal growth conditions, and mice
deﬁcient for BAG3 die shortly after birth due to the devel-
opment of a progressive muscle weakness [65]. In muscles,
a complex containing BAG3, its partner HspB8, CHIP, and
Hsp70 is constitutively needed for the maintenance of Z-
disks [66]. Loss of BAG3 activity in patients or transgenic
animals leads to a contraction-dependent disintegration of
Z-discs [65, 67]. The BAG3 complex is here needed for
clearance of damaged components such as ﬁlamin [66].
2.5. p62 Bodies, DALIS, and ALIS. There is an intimate
relationship between CASA and the formation of p62 bodies
(Figure 2(c)), but more studies are needed to verify whether
their formation is required for CASA or not. The contents
of p62 bodies are degraded by selective autophagy, and this
depends on a direct interaction of its major constituent p62
and its interaction partner NBR1, with ATG8 homologues
on the phagophore [30, 31]. The decision to form p62
bodies and to degrade misfolded substrates by CASA may
be decided by the BAG3:BAG1 ratio within the speciﬁc
cell. The link between BAG3 and the formation of p62
bodies was initially described by the group of Christian Behl
[68]. Strikingly, in aging cells, an increased level of BAG3
relative to BAG1 is responsible for a shift from proteasomal
towards autophagic degradation of misfolded proteins. This
correlates with an increased formation of p62 bodies [68].
A specialized type of protein aggregate clearly related
to p62 bodies is the dendritic cell aggresome-like induced
structures(DALISs)initiallystudiedbythegroupofPhilippe
Pierre [69, 70]. This type of ubiquitinated structure is tran-
siently formed in antigen-presenting cells such as dendritic
cells and macrophages during immune cell maturation. By6 International Journal of Cell Biology
using puromycin to induce the formation of DRiPs, they
showed that misfolded proteins accumulate in DALIS and
become ubiquitinated within these structures. DALIS is an
ordered type of structure distinct from aggresomes. The
formation of DALIS is stress-induced and transient and does
not depend on transport along microtubules [69, 70]. Later
studiesshowedthatsimilarstructurescanbeformedinmany
cell types in response to stressors like puromycin, oxidative
stress, starvation, and transfection, and they were therefore
given the name ALIS [71]. We noted that p62 is a major
protein in these structures and realized that ALIS and p62
bodiesareindistinguishablestructures[31].Therelationship
between p62 bodies and DALIS needs to be analyzed more
carefully. p62 bodies have been used by us as a term to
d e s c r i b ea g g r e g a t e sf o r m e db yp 6 2i nr e s p o n s et ov a r i o u s
stressors. A major role of p62 bodies is to serve as substrates
for selective autophagy. It is important to realize that some
types of p62 bodies may not be true ALIS, in the sense that
they may not fulﬁll the criteria as has been described for the
DALIS of dendritic cells [69, 70, 72]. We therefore consider
p62 bodies to represent a more broad type of structure, also
including aggregates that are diﬀerent from DALIS/ALIS.
An important role of DALIS during immune cell mat-
uration is MHC class I presentation, and this depends
on proteasomal degradation [73]. This actually also occurs
for DRiPs accumulated in ALIS in HeLa cells during
autophagy inhibition, although these DRiPs are normally
also autophagy substrates [74]. A recent study explored the
degradation of DALIS formed in dendritic cells, and this
study revealed that the contents of DALIS can be degraded
both by the proteasome and by selective autophagy [72].
In line with other studies, BAG3 is needed for selective
autophagy of these structures, but not for their proteasomal
degradation [72]. Degradation by the UPS is probably not a
speciﬁc feature of the DALIS but may occur with p62 bodies
of other cell types as well [71]. However, oxidative stress-
induced p62 bodies in pancreatic cells of diabetic rats are
only cleared by autophagy [75]. Possibly, the aggregation
status of proteins within the p62 body is an important
parameter that may regulate the recruitment of BAG3 to the
aggregate.
3.The DecisiontoFormAggregates
3.1. The Aggresome. The aggresome, formed in response
to proteasomal inhibition or overexpression of aggregation
prone proteins, is currently the best-studied protein aggre-
gate with respect to formation and degradation mechanisms.
The aggresome is located close to the nuclear envelope at the
microtubule organizing center (MTOC), and its formation
depends on microtubule-dependent transport of protein
aggregates [34, 76]. It is insoluble and metabolically stable.
The proteins of an aggresome are normally ubiquitinated
[77], and they are enclosed by intermediate ﬁlaments such
as vimentin and keratin, depending on cell type [34, 76].
Other types of inclusions observed in proteinopathies may
have a nuclear or more dispersed cytoplasmic location. The
formation of a speciﬁc type of inclusion is often associated
with the formation of a variety of smaller intermediates
that can be unstructured or have a variety of diﬀerent
types of structures [1]. A study reported two diﬀerent
types of aggresome-like structures found both in yeast and
mammalian cells called the “juxtanuclear quality control”
(JUNQ) and “insoluble protein deposit” (IPOD) that diﬀer
from the classical deﬁnition of an aggresome since they do
not localize to the MTOC [78]. Both of these structures
require microtubular transport for their formation. IPODs
are localized to the cell periphery often near vacuoles, and
the aggregates do not contain ubiquitin. JUNQ, on the
other hand, is localized close to the nucleus and contains
ubiquitinated proteins and associated proteasomes. More
studies are required to determine the relationships between
these diﬀerent “aggresomes.”
What should be noted is that aggregation may also be
part of an important functional state of some proteins. One
example is the autophagy receptor p62 which is present in
almost all types of protein aggregates. p62 is continuously
degraded by autophagy, and this relies on its ability to
polymerize [29]. What type of overall structure p62 forms
in order to be degraded is not known, but this is a relevant
question since this intrinsic structure may also be essential
for the structural and functional role of p62 in protein
inclusions. Proteins like p62, ALFY (autophagy-linked FYVE
protein), and likely also NBR1 (neighbor of BRCA1 gene),
are general contents of protein inclusions and are believed to
be there because they are involved in both their construction
and their degradation by autophagy [26, 28, 30, 31, 79–81].
There is also an ongoing discussion whether it is the mature
inclusions or the intermediate precursors that are degraded
by autophagy. Two independent pathways have so far been
described for the formation of an aggresome, distinguished
by whether it is histone deacetylase 6 (HDAC6) or BAG3 that
mediates the actual transport of aggregates to the aggresome
(Figures 2(d) and 3(d)).
3.2. HDAC6: Transport of Aggregates and Autophagosomal
Maturation. HDAC6 facilitates dynein-mediated transport
of ubiquitinated substrates to the aggresome, and it is also
important for the clearance of aggresomes by autophagy [77,
82, 83]( Figure 3(d)). These roles of HDAC6 are in particular
important under conditions when proteasomal degrada-
tion is impaired and misfolded proteins are preferentially
degraded by autophagy [46, 84]. HDAC6 interacts directly
withdyneinandwithubiquitinatedsubstratesandhasapref-
erence for K63-linked polyubiquitin chains [83, 85]. In addi-
tiontoaroleinaggregateformationandaggrephagy,HDAC6
has a role in maturation of autophagosomes and knockdown
of HDAC6 results in the accumulation of autophagosomes
[86]. These autophagosomes contain ubiquitinated proteins,
demonstrating a role for HDAC6 in the maturation of a
subset of autophagosomes involved in selective autophagy of
misfolded proteins. The role of HDAC6 in this process is to
regulate the actin cytoskeleton [86]. HDAC6 and p62 may
act sequentially in the degradation of ubiquitinated protein
aggregateswithp62 recruiting phagophores tothe aggregates
for autophagosome formation and HDAC6 acting at the
maturation step enhancing fusion between autophagosomes
and lysosomes by remodeling actin [83].International Journal of Cell Biology 7
3.3. BAG3-Mediated Formation of Aggresomes. BAG3 and
CHIP are both needed for targeting of Hsp70 substrates to
the aggresome [38]( Figure 2(d)). BAG3 interacts directly
with dynein, and this directs transport of Hsp70 substrates
to the aggresome [87]. This transport does not depend
on ubiquitination of substrates, although the E3 ubiquitin
ligase CHIP is required [38]. Depletion of CHIP inhibits
aggresome formation in response to proteasomal inhibition,
whereas expression of a dominant negative CHIP that does
notinteractwithE2conjugationenzymesinducesaggresome
formation [38]. Hence, in the absence of proteasomal degra-
dation or CHIP-mediated ubiquitination, CHIP induces
aggregation and BAG3-mediated transport of misfolded
substrates, resulting in the formation of aggresomes. Hence,
BAG3 may play an important role in recruiting non-ubiqui-
tinated substrates to the aggresome [87].
3.4. p97/VCP: An Ubiquitin-Associated Hsp-Independent
Molecular Chaperone. The AAA-ATPase family protein
p97/VCP (valosin-containing protein) is a molecular chap-
erone with important roles in cell division, organelle bi-
ogenesis, nuclear envelope formation, and protein degra-
dation [88]. To understand the diversity of cellular roles
displayed by p97/VCP, it is important to look at the roles of
the various cofactors it interacts with. Most of these interac-
tionsaremediatedbytheN-terminaldomain,whileafeware
mediated by the C-terminal 10 amino acids [89]. Functional
roles are known only for a subset of these interactions, but
the majority of p97/VCP cofactors have a clear connection
to ubiquitin. Loss of p97/VCP in mammalian cells results
in accumulation of insoluble ubiquitinated proteins [90–
92]. Functional p97/VCP is a homohexamer, and ATP
hydrolysis is associated with conformational changes and
release of substrates and cofactors [93]. Several studies
support a “segregase” activity of p97/VCP, in which ATP
hydrolysis is used to segregate ubiquitinated substrates from
protein complexes, cell membranes, and chromatin [94–96]
(Figures 3(a)–3(c)). p97/VCP is located in the cytoplasm
and nucleus and is recruited to the ER membrane in
response to ER stress. In ERAD, p97/VCP interacts with
the integral ER membrane protein Derlin-1 to unfold,
transfer, and extract UPS substrates from the ER mem-
brane [97]( Figure 3(a)). Several ERAD-directed E3 ligases
have been detected in mammalian cells, including Hrd1
and gp78 [98]. p97/VCP also plays a role in autophagic
degradation of damaged mitochondria after treatment with
CCCP (Figure 3(b)). In this case, it is needed for the
extraction and delivery of mitochondrial mitofusins to the
UPS, after they ﬁrst have been ubiquitinated by Parkin
[99, 100].
No crosstalk between p97/VCP and the Hsp70/Hsp90
molecular chaperones is reported, and cellular roles medi-
ated by p97/VCP may therefore be distinct from those
displayed by the other group of molecular chaperones.
Interestingly, overexpression of p97/VCP inhibited accumu-
lation of ubiquitinated proteins in autophagy deﬁcient cells
overexpressing p62, indicating that there may be a com-
petitive relation between p62 and p97/VCP for the binding
to ubiquitinated substrates [101]. p97/VCP is important
for aggresome formation in mammalian cells in response
to proteasomal inhibition [92, 102–104]. p97/VCP is pro-
posed to induce aggresome formation via a delivery of
ubiquitinated protein aggregates to HDAC6 (Figure 3(d)),
but the relation between p97/VCP and HDAC6 in this
process is only partially understood [105]. Similar to
HDAC6, p97/VCP is involved in maturation of autophago-
somes. Knockdown of p97/VCP leads to accumulation
of autophagosomes containing ubiquitinated substrates
[106].
Mutations in p97/VCP cause inclusion body myopathy
associated with Paget’s disease of the bone and fron-
totemporal dementia (IBMPFD) [107]. Structural data for
p97/VCP mutants reveals conformational changes in the
N-terminal domain [108]. This has a strong eﬀect on
cofactor interactions, and some interactions like binding of
the ubiquitin ligase E4B are reduced whereas others, like
binding of the DUB ataxin 3, are increased [109]. Myoblasts
expressing IBMPFD mutants of p97/VCP have defects in
degradation of ERAD substrates [110], and their expression
in myoblasts or transgenic mouse muscle leads to accumu-
lation of ubiquitinated aggregates [110, 111]. Aggresome
f o r m a t i o ni nc e l lc u l t u r ei sa l s oa ﬀected by mutant p97/VCP
expression [102, 103]. FRAP analyses suggest that it is the
release of substrates from p97/VCP that is impaired, so that
aggregation-prone proteins are not delivered to HDAC6 and
therefore accumulate in peripheral aggregates lacking p62
and LC3 [102]. The failure to form aggresomes could be
rescued by HDAC6 overexpression [102], suggesting that
HDAC6 has a protective role.
3.5. Ubiquilin-1: A Ubiquitous Distributor and Chaperone.
Ubiquilin-1 is another protein linked to the sorting of
misfolded proteins to diﬀerent degradation systems. But
ubiquilin-1 is also a chaperone needed for folding and
stabilization of speciﬁc client proteins. The four mammalian
ubiquilins have a domain structure reﬂecting that of p62,
with a ubiquitin binding C-terminal UBA domain and an
N-terminal UbL domain interacting with the Rpn10/S5A
proteasomal subunit [112, 113]. Ubiquilin-1 is involved in
ERAD as part of a complex with erasin and p97/VCP [114].
More recent studies have indicated a role for ubiquilin-1 in
delivery of proteins to CMA or to autophagy. Ubiquilin-
1 is itself degraded by both pathways [115]. Ubiquilin-1 is
also involved in the delivery of proteins to the aggresome
[116–118], and it protects against polyQ-induced cell death
in cellular and invertebrate models of Huntington’s disease
[119, 120]. It may also promote autophagic degradation of
protein aggregates [121, 122]. Ubiquilin-1 has an intrinsic
chaperone activity in vitro [123], and it seems to act as
a chaperone for the aggregation-prone amyloid precursor
protein (APP) [123]. In HeLa cells, expression of ubiquilin-
1 reduces toxicity associated with APP and protects against
aggregationofAPP[123].BrainsofAlzheimer’sdisease(AD)
patients often have a decreased level of ubiquilin-1 which
may contribute to late-onset AD [123].8 International Journal of Cell Biology
4.LinkingProteinAggregateswith
the Phagophore
4.1. p62 and NBR1. Selective autophagy depends on auto-
phagy receptors like p62 and NBR1. These proteins are
themselvesdegradedbyautophagyduetoadirectinteraction
with ATG8 family proteins conjugated to PE and bound
to the phagophore membrane [26, 28–31]. p62 and NBR1
share a similar domain architecture, both containing an N-
terminal PB1 domain and a C-terminal UBA domain [124].
The interaction between p62 or NBR1 and ATG8 homo-
logues is mediated via a short, linear LIR motif in p62 and
NBR1 [29–31, 125, 126]. The p62 LIR has the core motif
DDDWTHL. Following the initial discovery of an LIR in
p62 [31], this motif has been identiﬁed in an increasing
list of proteins. Based on characterized LIR motifs, the
present consensus sequence is D/E-D-W/F/Y-x-x-L/I/V [26].
The LIR interaction surface of ATG8 proteins has two
hydrophobic pockets accommodating the aromatic (W/F/Y)
and the hydrophobic side chains (L/I/V) of the core motif,
and the acidic residues often interact with basic residues of
the N-terminal arm of the ATG8s [29, 125–127]. Lipidated
ATG8 proteins are located both on the inner and outer
surfaces of autophagic vesicles, and they therefore make
a perfect scaﬀold for speciﬁc recruitment of proteins to
the phagophore or the autophagosome. p62 is a polymeric
protein, and polymers are made via head-to-tail interactions
betweenPB1domains[124,128].ThePB1domain-mediated
polymerization is essential for the selective degradation of
p62 by autophagy [29], and it is required for the targeting
of p62 to the autophagosome formation site at the ER [40].
It is also crucial for the ability of p62 to assemble proteins
into aggregates [28]. p62 and NBR1 have a very diﬀerent
primary sequence, and NBR1 contains several domains that
are not present in p62. Homologs of NBR1 are found
throughout the eukaryotic kingdom, whereas the presence
of p62 is unique for metazoans and likely the result of a
duplication event early in the metazoan lineage [129]. Plant
NBR1 is able to polymerize via the PB1 domain, and this
is required for autophagic degradation similar to metazoan
p62 [129]. During evolution, NBR1 has lost the ability to
polymerize via the PB1 domain, while p62 has lost several
domains like the FW domain. Therefore these two proteins
may have independent roles in selective autophagy, but they
may also cooperate as indicated by the fact that p62 interacts
directly with NBR1 [124]. Recently, several other autophagy
receptors in addition to p62 and NBR1 have been identiﬁed.
These are ATG32 and NIX/BNIP3L acting in mitophagy
[130–132], NDP52 and optineurin in xenophagy [133, 134],
and Stbd1 in degradation of glycogen [135]. However, only
p62 and NBR1 have so far been linked to degradation of
protein aggregates.
It should be noted that p62 is also involved in selective
autophagy of non-ubiquitinated substrates, and selective
autophagy of a mutant superoxide dismutase 1 (SOD1)
causing ALS depends on a direct and ubiquitin-independent
interaction between SOD1 and p62 [136]. Recently, p62 was
found to be required for selective autophagic clearance of a
non-ubiquitylated substrate, an aggregation-prone isoform
of STAT5A (STAT5A ΔE18) that formed aggresomes and/or
aggregates by impairment of proteasome functioning or
autophagy [137]. Diﬀerent domains of p62 interacted with
SOD1 and STAT5A in these cases. A third example of p62-
mediated selective autophagy of non-ubiquitin substrates is
the p62-mediated autophagic clearance of Sindbis virus cap-
sids from neurons of infected mice [138]. A bona ﬁde exam-
pleofubiquitin-independentaggrephagyisseeninC.elegans
where the polymeric autophagy receptor SEPA-1 binds to the
P granule component PGL-3 and to the ATG8 homologue
LGG-1 to mediate the selective autophagic degradation of
Pg r a n u l e s[ 139]. This way the maternally derived germ P
granule components are degraded by aggrephagy in somatic
cellsduringembryogenesis.However,inmostcasesubiquitin
binding seems to be important and a study on the role of p62
and ubiquitin in pexophagy clearly indicates that ubiquitin
may serve as a label that is recognized by p62 [140]. Less
is known about the role of NBR1 in selective autophagy,
mainly because it is less studied. p62 has been implicated in
the autophagic clearance of midbody ring complexes [141],
and recently NBR1 was found to be required and more
important than p62 for clearance of midbody derivatives by
autophagy [142]. It was found that disposal of midbody
derivatives accompanied stem-cell diﬀerentiation and that
the autophagy receptor NBR1 bound to the midbody protein
CEP55 to mediate the autophagic degradation.
4.2. ALFY. ALFY is a 400kDa scaﬀold protein with an
ensemble of domains located to its C-terminal region. This
part of ALFY contains a BEACH domain, an ATG5 inter-
acting WD40 repeat region [80], and a PtdIns(3)P-binding
FYVE domain [143]. Co-immunoprecipitation experiments
indicatethattheBEACHdomaininALFYisimportantforits
ability to form complexes in vivo with p62 [79]. ALFY and
p62 colocalize strongly in cytoplasmic and nuclear protein
aggregatesincellculture[79,80],andtheyarebothdegraded
by autophagy in response to the formation of p62 bodies
in HeLa cells [79]. In fact, p62, NBR1, and ALFY are all
importantforselectiveautophagyofp62bodiesinHeLacells
[30, 31, 79].
ALFY is under normal conditions mainly nuclear. In
response to amino acid starvation or puromycin-induced
accumulationof DRiPs,ALFYis redistributed tocytoplasmic
p62 bodies [79]( Figure 2(d)). It is also redistributed to
cytoplasmic polyglutamine inclusions [80] and to aggregates
induced in response to proteasomal inhibition [143]. The
redistribution of ALFY in HeLa cells depends on p62 and
seems to depend on the ability of p62 to shuttle between the
cytoplasm and the nucleus [79]. Autophagic degradation of
ALFY most likely depends on its association with p62 and/or
cytoplasmic protein aggregates [79, 80].
ALFY is required for aggrephagy, but not for starvation-
induced autophagy [80]. Knock-out studies have revealed
an important role of ALFY in constitutive autophagy of
m i s f o l d e dp r o t e i n s ,b o t hi nm a m m a l sa n di nﬂ i e s[ 80,
144]. In ﬂies, knockout of the Drosophila homologue blue
cheese (bchs) results in accumulation of ubiquitinated pro-
tein inclusions, neurodegeneration, and a reduced life-spanInternational Journal of Cell Biology 9
[144]. Furthermore, overexpression of Bchs reduces neuro-
toxicity in a Drosophila eye model of polyglutamine toxicity
[80]. In mammals, ALFY is recruited to cytoplasmic and
nuclear protein inclusions as part of a complex containing
p62, NBR1, LC3, ATG5, ATG12, and ATG16L [80]. In mam-
maliancellculture,ALFYisrequiredforeﬃcientdegradation
of polyglutamine and α-synuclein inclusions. This depends
on a direct interaction between ALFY and ATG5 [80].
Notably, overexpression of the C-terminal part of ALFY
alone promoted degradation of polyglutamine inclusions in
an e u r o n a ll e n t i v i r a lm o d e l[ 80]. Very likely, co-recruitment
of p62, NBR1, and ALFY and their interaction partners, to
a protein aggregate, initiates the formation of autophagy
membranes. However, more studies are needed to identify
the speciﬁc roles mediated by each of these proteins recruit-
ing diﬀerent components of the autophagy machinery for
autophagosome formation at the protein aggregate.
5. Regulation of Aggrephagy by
PosttranslationalModiﬁcations
The selective autophagy of protein aggregates is regulated at
the level of the autophagic machinery, the level of autophagy
receptors, like p62, NBR1, and ALFY, and the level of the
protein aggregates [81, 145]. Hitherto, there is a scarcity of
data available to illuminate the mechanisms involved in reg-
ulating aggrephagy. However, both autophagy receptors and
substrates are regulated by posttranslational modiﬁcations
including ubiquitination, phosphorylation, and acetylation
[146].
K63-linked polyubiquitin chains have been associated
with autophagic degradation [147, 148], and this may clearly
have a role in recruiting autophagy receptors like p62 and
NBR1 [30, 149]o rH D A C 6[ 85] .S o ,i st h e r eas i m p l e
ubiquitin-code where substrates tagged with K48-linked
ubiquitin chains are degraded by the UPS while aggregated
substrates tagged with K63-linked ubiquitin are degraded by
autophagy? Several of the proteins involved in aggrephagy,
like p62 and HDAC6, bind preferentially to K63-linked ubiq-
uitin [85, 149]. The E3 ligase TRAF6 interacts with p62, and
it also catalyzes K63-linked ubiquitination of its substrates
[150]. Formation of aggresomes requires the activity of the
deubiquitinatingenzymeataxin-3whichcanbindtoHDAC6
and trims both K48- and K63-linked ubiquitin chains [151,
152]. Hence, ataxin-3 (and other DUBs) may be required for
editing the ubiquitin code to one favouring aggrephagy [83].
Note that mutant polyQ-expanded ataxin-3 is an aggregate-
prone protein that causes spinocerebellar ataxia type 3 that
is degraded by autophagy in a mouse model of this disease
[153]. The DUB cylindromatosis tumor suppressor (CYLD)
interacts with TRAF6 to remove K63-linked ubiquitin in a
p62-dependent manner [154]. Hence, in addition to binding
to ubiquitinated aggregates, p62 may also be involved in
regulatingtheK63-linkedubiquitinationofaggregatesacting
as autophagy substrates through its interactions with TRAF6
and CYLD. In brains of p62 KO mice, there was a hyperac-
cumulation of K63-linked ubiquitin in the insoluble fraction
suggesting accumulation of substratesand also dysregulation
of the TRAF6-CYLD interplay in the absence of p62 [154].
These mice showed AD-like symptoms, and aggregated K63-
ubiquitinated tau protein was recovered from brain fraction-
ation experiments [155]. Not surprisingly, TRAF6 is found
in the Lewy bodies in sporadic Parkinson’s disease (PD)
brains [156]. TRAF6 also regulates autophagy positively by
mediatingK63ubiquitinationofbeclin1,andthisisopposed
by the DUB A20 [157].
The autophagy pathway is directly regulated by several
kinases including Ulk1/2, mTOR, AMPK, and PKA. In
addition, autophagy receptors like p62 and optineurin, as
well as LC3B, have recently been shown to be regulated by
phosphorylation [134, 158, 159]. PKA-mediated phosphory-
lation of a site in the N-terminal arm of LC3 inhibited its
recruitmenttoautophagosomes[158].TANKbindingkinase
1 (TBK1) phosphorylated optineurin on Ser-177 in the
LIR motif, enhancing LC3 binding aﬃnity and autophagic
clearance of cytosolic Salmonella showing that the LIR-LC3
interactioncanberegulatedbyphosphorylation[134].Phos-
phorylation of p62 on Ser-403 in the UBA domain increased
the aﬃnity for polyubiquitin and stimulated aggrephagy
of ubiquitinated proteins [159]. Interestingly, recently a
number of reports show that, similar to p62, also optineurin
is found in ubiquitin-positive inclusions in sporadic and
familial ALS, neuroﬁbrillary tangles and dystrophic neuritis
in AD, and LBs in PD and more neurodegenerative diseases
(see that is, refs. [160–162]). Optineurin was recently found
to be mutated and causatively linked to the disease in some
casesoffamilialALS[160].Mutationsofoptineurinhavealso
been found in sporadic ALS [163].
The aggregating substrates can be phosphorylated in a
manner aﬀecting their clearance. A number of studies report
on phosphorylations aﬀecting cleavage, aggregation, and
clearance of aggregation-prone polyQ-expanded proteins
including huntingtin and ataxin-1 and 3 (see [81]). It has
long been recognized that phosphorylation of tau aﬀects
its aggregation. In the brains of adult p62 knock-out mice,
an age-dependent increase in the activity of several kinases,
including glycogen synthase kinase 3β (GSK3β), protein
kinase B (PKB), mitogen-activated protein kinases, and c-
Jun-N-terminal kinase, results in hyperphosphorylated tau
and formation of neuroﬁbrillary tangles [155].
Members of the basic autophagy apparatus including
Atg5, 7, 8, and 12 can be acetylated by the acetyltransferase
p300, and p300 binds directly to Atg7 [164]. Acetylation
of these proteins mediated by p300 inhibits autophagy, and
silencing of p300 increases autophagy ﬂux [164]. Acetylation
was also recently shown to aﬀect the autophagic clearance
of a fragment of mutant huntingtin and an N-terminal
caspase-7cleavagefragmentofataxin-7.Acetylationoflysine
444 (K444) increased autophagic degradation of mutant
huntingtin [165]. This acetylation also mitigated the toxic
eﬀects of mutant huntingtin in primary striatal and cortical
neuronsandinatransgenicC.elegansmodelofHuntington’s
disease. Mutant huntingtin resistant to acetylation accumu-
lated and led to neurodegeneration in cultured neurons and
in mouse brain [165]. The opposite eﬀect of acetylation was
seen for ataxin-7 [166]. Cleavage of ataxin-7 by caspase-
7 generates toxic N-terminal polyQ-containing fragments
that accumulate with disease progression. Acetylation of10 International Journal of Cell Biology
lysine 257 (K257) adjacent to the caspase-7 cleavage site of
ataxin-7 promotes accumulation of the fragment, while the
unmodiﬁed ataxin-7 fragments are degraded by autophagy
[166].
6 .Ot h e rR eg u l a t o ryA s pec t s
So far very little is known about diﬀerential gene regulation
occurring as a result of aggregate formation. There is clearly
a link between aggregate formation and oxidative stress
responses. p62 binds to the cytoplasmic inhibitor KEAP1
to stabilize the oxidative stress response transcription factor
Nrf2, which then induces a repertoire of oxidative stress
response genes [167–170]. The p62 gene is itself one of the
targets of Nrf2 enabling p62 to set up a positive feedback
loop [168]. Deprenyl, which is a candidate neuroprotective
drug in PD, can also lead to nuclear accumulation of Nrf2
and induction of oxidative stress response genes [171].
Transcription of the p62 gene is increased during aggregate
formation induced by proteasomal inhibition [172]. Activa-
tion of the p62-Nrf2 pathway may therefore be an important
protective response during aggregate formation and a target
for development of neuroprotective drugs.
Several central proteins involved in aggrephagy including
Beclin 1, diabetes- and obesity-regulated gene (DOR), p62,
and ALFY shuttle between the nucleus and cytosol (see
[81]). The nucleocytoplasmic shuttling of p62 is regulated
by phosphorylation sites at or C-terminal to the major
nuclearlocalizationsignal[173].I nthenucleusbothp62and
ALFY may be involved in collecting ubiquitinated proteins
in the PML (promyelocytic leukemia) nuclear bodies for
proteasomal degradation [173]. Whether substrates can be
transported out of the nucleus for degradation by autophagy
is an open question.
7. Is the Aggregate Eaten in One Big Bite or in
Smaller Pieces?
It is now well established that autophagy is needed for the
removal of cytoplasmic protein inclusions [80, 82, 174–
176]. But are the insoluble inclusions solubilized or modiﬁed
before engulfment? There seems to be a putative conﬂict
betweenthecagingofprotein aggregateswithinintermediate
ﬁlaments such as vimentin or keratin [34, 76] and the
degradation of these aggregates by autophagy. However,
knock-out studies of genes associated with aggregation
indicate a positive role for aggregation in autophagy [82].
In AD, autophagosomes with electron dense amorphous
or multilamellar contents accumulate in massive numbers
[177]. The accumulation of protein aggregates or inclusions
has also been demonstrated in cell culture. Immunoelectron
microscopy on mammalian cells stably expressing Htt103Q
revealed that insoluble polyglutamine inclusions are found
within autophagosomes [80]. SDS-insoluble Htt103Q was
in this case also found in autophagosome fractions after
cellfractionation, clearly demonstrating that insoluble inclu-
sions are indeed engulfed by autophagic structures. Also p62
bodies have been shown by immunoelectron microscopy to
accumulate inside autophagosomes [31]. It is in this context
relevant that other large cellular structures such as organelles
and bacteria are degraded by selective autophagy [26], and
there is no evidence that these structures are cut into smaller
pieces before they are engulfed.
In non-metazoan species, including plants and fungi,
Hsp104 forms a complex with Hsp70 and Hsp40 that
has disaggregation activity capable of dissolving amyloid-
like structures [178]. No homolog of Hsp104 exists in
metazoans, but a less potent disaggregation activity was
recently shown for a mammalian complex consisting of
Hsp110, Hsp70, and Hsp40 [179]. The observed presence
of insoluble inclusions within autophagic vesicles does not
excludethatanotherrouteofdegradationismoreimportant,
andstudiesondegradationofaggregation-proneproteinsare
oftenconfusedbythefactthattheirsolubleformscanalsobe
degraded by CMA or the UPS. The long-standing question
whether it is the large aggregate which is degraded whole-
sale or if it is dismantled into smaller aggregates that are
engulfed by forming autophagosomes still remains unans-
wered.
8.DysfunctionofAutophagyinProteinopathies
Macroautophagic stress indicates a situation when the
normal ﬂow of autophagic degradation is impaired [180].
If macroautophagic stress is caused by defects in protein
degradation pathways, the eﬀect is impaired degradation of
misfolded proteins and accumulation of protein aggregates.
But often, the ﬁrst indication that autophagy is aﬀected
in neurodegenerative diseases and disease models is an
abnormal number of autophagosomes and/or amphisomes
(fusion product of autophagosomes and late endosomes)
(reviewed in [181]). In this case, the defect in autophagy
is caused by impaired endocytosis at the late endosome-
lysosome level, inhibition of autophagosome maturation,
and/or inhibition of lysosomal degradative functions. The
pressure on autophagy is increased during aging, in part
because CMA activity declines. This is mainly caused by
decreased levels of LAMP-2A at the lysosomal membrane
[182]. Autophagosome formation declines during aging due
to decreased expression of some of the vital autophagy pro-
teinslikeATG8familyproteinsandBeclin1[183,184].Aging
is associated with increased intracellular oxidative stress
leading to increased unfolding of proteins. Combined with
a decline in autophagosome maturation and/or lysosomal
degradation, this helps explaining the late-onset phenotypes
often observed for several of the proteinopathies. Induction
of autophagosome formation is often suggested as a solution
to the problem of macroautophagic stress, and it has shown
promising results in cell culture and in vivo models [39,
185]. But in other cases autophagosome formation is not a
solution, since maturation of autophagosomes or lysosomal
degradation is impaired. Caution is therefore required before
trying to boost autophagy as a therapeutic strategy in
neurodegenerativediseases.Itisimperativetoﬁrstdetermine
the main cause of dysfunctional autophagy in the diﬀerent
types of proteinopathies before trying to boost or inhibit
autophagy/aggrephagy as a therapy.International Journal of Cell Biology 11
8.1. Accumulation of p62: Proteinopathies in Liver and Mus-
cle. p62 is present in almost all cytoplasmic and nuclear
inclusions found in human diseases [186–189]. In most pro-
teinopathies, another aggregation-prone protein is responsi-
ble for the formation of the aggregate, and p62 is recruited
later and possibly in response to ubiquitination of the aggre-
gate.Anexampleispolyglutamineinclusionsthatareformed
independently of p62 [190]. However, p62 is together with
NBR1 and ALFY important for the formation and degrada-
tion of p62 bodies in response to puromycin treatment or
starvation of HeLa cells [30, 31, 79]. These structures are
highly ubiquitinated and substrates for selective autophagy
[28, 31]. p62 is also crucial for the formation of two types
of pathogenic aggregates found in chronic liver diseases
[188, 191], that is, intracellular hyaline bodies found in
hepatocellular carcinoma and Mallory-Denk bodies (MBs)
found in alcoholic and nonalcoholic steatohepatitis. Similar
to p62 bodies, p62 and ubiquitin are major constituents
of these structures, but MBs in addition contain abnormal
keratins [191]. Most likely, their formation is initially caused
byinsuﬃcientdegradationofp62bodiesbyautophagy.What
should be noted is that the level of ALFY in the liver is very
low [143], and it is tempting to speculate that the tendency
of p62 to form aggregates in hepatocytes is caused by this.
Apart from Paget’s disease of the bone aﬀecting the skeleton,
liver is the only organ where p62 has been shown to play a
main role in the formation of protein aggregates in human
disease.
Autophagy knock-out studies support the hypothesis
that p62 bodies develop into stable aggregates if autophagy
is impaired. In mice, tissue-speciﬁc knockout of autophagy
causes accumulation of p62-containing aggregates in neu-
rons [53, 54, 192], hepatocytes [55], skeletal muscle [51,
52], cardiac muscles [193], pancreatic β cells [194, 195],
and kidneys [196]. A similar accumulation of ubiquitinated
aggregates is seen after knockout of autophagy in ﬂies
[184, 197]. Importantly, p62, or the Drosophila homologue
Ref(2)P, is required for the formation of ubiquitinated
protein aggregates under autophagy knock-out conditions,
both in cell culture and in vivo [28, 31, 55, 198]. The most
likely interpretation is that p62-mediated accumulation of
ubiquitinated proteins in p62 bodies results in the formation
of aggregates that in the absence of autophagy cannot be
degraded [55]. In cells lacking p62, the contents of the
aggregates are likely to be degraded by the UPS or CMA
and the eﬀect of autophagy inhibition is therefore less
pronounced. Blockade of autophagy may in fact inhibit the
UPS if the p62 level gets very high because p62 may inhibit
substrate delivery to the proteasome [101].
NBR1 colocalizes with p62 in the Mallory-Denk bodies
inpatientswithalcoholicsteatohepatitis[30],andmaythere-
fore contribute to the formation of aggregates in liver. NBR1
also colocalizes with p62, LC3, and phosphorylated tau in
ubiquitinated protein aggregates of sporadic inclusion-body
myositis (s-IBM) that is the most common degenerative
myopathy associated with aging [199, 200]. Hence, it is very
likely that p62 and NBR1 cooperate in clearance of protein
aggregates by autophagy.
8.2. Proteinopathies in Neurodegeneration. There is very little
LC3-IIorautophagosomesinhealthyneurons,butthisisdue
to a very rapid turnover of autophagosomes [177]. Neurons
may therefore be vulnerable to inhibition of the ﬂow of
autophagosomes at any step downstream of autophagy
formation. Autophagy of proteins is part of the normal
functionofpostmitoticneuronsandisconstitutivelyneeded.
Conditional knockout of autophagy in mice causes neuronal
degeneration and accumulation of ubiquitinated protein
aggregates[53,54].Thisclearlydemonstratesthatautophagy
delays the onset of neurodegenerative diseases. The major
component of inclusions formed in neurodegenerative dis-
eases is often a single protein, and the most common
intracellular neuronal proteinopathies are formed by α-
synuclein, tau, TDP-43 (transactive response DNA-binding
protein-43), or a mutated protein with extended polyglu-
tamine repeats (see refs. [81, 145, 181, 201]). Aggregation-
prone proteins that are mutated in disease are often used
as models to study protein aggregation and aggrephagy.
Among the best studied neurodegenerative diseases are the
α-synucleinopathies caused by aggregation of α-synuclein
and responsible for diseases like Parkinson’s disease (PD)
and dementia with Lewy bodies [202]. These diseases are
characterizedbytheaggregationofα-synucleinintoso-called
Lewy bodies (LBs), but PD is also associated with lysosomal
dysfunction and mitochondrial dysfunction [180, 203]. The
LBs of PD and dementia with LBs are likely the disease-
associated aggregates morphologically most similar to a
“classical” aggresome [204–206]. HDAC6 is a component of
LBs, and the formation of LBs depends on ubiquitination
of substrates by Parkin and transport mediated by HDAC6
[77, 85]. The α-synuclein is degraded by CMA or autophagy
[207–209]. In PD and certain tauopathies, there is a block in
CMA because accumulation of α-synuclein or toxic forms of
tau inhibit the CMA translocation complex [207, 210, 211].
Such inhibition of CMA may play a key role in the develop-
ment of these disorders [181], and it may be responsible for
the observed activation of autophagy in PD [209]. Induction
of autophagy may have a protective eﬀect on α-synuclein-
related diseases [212–214]. However, too much autophagy
may be toxic if maturation of autophagosomes is impaired.
Activation of autophagosome formation may therefore be
beneﬁcial at early stages of the disease but may lead to
enhanced neuronal degeneration in other settings [180].
Another group of neurodegenerative diseases are 10 dif-
ferent autosomal dominant disorders caused by aggregation
of polyglutamine stretches on proteins [201]. These are
caused by genes that contain a stretch of repetitive CAG
glutamine codons that is unstable and tends to expand.
The tendency of polyglutamine stretch containing pro-
teins to aggregate is proportional to the number of glu-
tamine repeats. For Huntington’s disease (HD) caused by
aggregation of Huntingtin (Htt) fragments, a stretch of
around 40 glutamines may be suﬃcient to cause a disease
[201]. Polyglutamine-expanded mutant Htt is degraded by
autophagy, and autophagy reduces the toxicity associated
with mutant Htt expression both in cell culture and in
mouse, ﬂy, and zebraﬁsh models of Huntington’s disease [46,
175, 185, 215, 216]. Autophagy also has a role in clearance of12 International Journal of Cell Biology
other polyglutamine-expanded proteins, including mutant
ataxin-3 that is causing the spinocerebellar ataxia type 3
(SCA3) [153]. However, in a ﬂy model of dentatorubral-
pallidoluysian atrophy (DRPLA), a disorder caused by mu-
tations in the atrophin-1 protein, autophagy induction
was unable to rescue the degenerative phenotype because
lysosomal degradation was impaired [217]. There is also
evidence that mutant Htt has a negative eﬀect on selective
autophagy aﬀecting cargo recognition causing accumulation
of “empty” autophagosomes as analyzed by immunoEM
[218].
Several neurodegenerative diseases are characterized by
inclusions of hyperphosphorylated forms of the microtu-
bule-associated protein tau [219]. The most common and
best known disease with tau inclusions is Alzheimer’s disease
(AD). Tau forms neuroﬁbrillary tangles in AD, but also
soluble oligomers of hyperphosphorylated tau contribute
to neuronal degeneration [220]. AD is also associated with
plaques of amyloid-β (αβ) peptide produced by cleavage of
amyloid precursor protein (APP) by β-a n dγ-secretases. In
a mouse model, induction of autophagy delayed the onset
of AD although it had no eﬀect at later stages associated
with formation of plaques and tangles [221]. Tau binds
tubulin, and the normal function of tau is to promote
stabilization of microtubules in neuronal axons. This is
needed for long-distance transport and for the maintenance
of cellular morphology. Hyperphosphorylated tau has a
reduced aﬃnity for tubulin, and this is believed to result in
destabilization of microtubules [219]. As mentioned above,
p62 knock-out mice display an AD-like phenotype as they
grow older and their brains contain increased amounts
of hyperphosphorylated tau and K63-linked ubiquitinated
proteins [154, 155].
In a cell model, transport of tau to the aggresome in
response to proteasomal inhibition was inhibited by knock-
down of HDAC6, and this inhibited clearance of tau aggre-
gates and resulted in an accumulation of insoluble tau [222].
However, although the level of HDAC6 is elevated in AD
brain [223] HDAC6 is not present in neuroﬁbrillary tangles
o rs e n i l ep l a q u eo fA D[ 224]. Tau binds to HDAC6 [223],
and is an inhibitor of HDAC6 function [225]. HDAC6
knock-out mice have hyperacetylated tubulin, but they are
viableanddevelopwithoutneurologicalabnormalities[226].
Consistent with this, increased acetylation of tubulin is also
found in brain of AD patients. However, tau also inhibits
the role of HDAC6 in aggresome formation [225]. Inhibition
of aggresome formation favors the formation of smaller and
possibly more toxic aggregates and will also have a negative
eﬀect on tau degradation.
IBMPFD caused by mutations in p97/VCP primarily
aﬀects muscle, brain, and bone tissue and is characterized by
the accumulation of cytoplasmic and nuclear ubiquitinated
inclusions [107]. Recently, TDP-43 was shown to play a
role in frontotemporal dementia induced by expression of
mutants of p97/VCP [227, 228]. In a Drosophila model of
IBMPFD induced by mutant p97/VCP, an elevated level of
TDP-43 is directly responsible for the degeneration [228].
TDP-43-positive inclusions are hallmarks of frontotemporal
dementia and amyotrophic lateral sclerosis (ALS), and there
seems to be a lack of HDAC6 in these inclusions [223].
This correlates with the recent ﬁnding that TDP-43 binds
to HDAC6 mRNA and knockdown of TDP-43 destabilizes
HDAC6 mRNA and leads to downregulation of HDAC6
expression. This causes reduced aggregate formation and
increased cytotoxicity in cells expressing a polyQ-expanded
ataxin-3 mutant [229]. A novel surprising ﬁnding is that
TDP-43 appears to stabilize ATG7 mRNA by binding to it via
its RRM1 domain. Depletion of TDP-43 caused reduction of
the ATG7 mRNA/protein and inhibition of autophagy lead-
ing to accumulation of polyubiquitinated proteins and p62
[230]. Hence, functional TDP-43 is important for eﬃcient
autophagy.
The reason why IBMPFD mutants of p97/VCP cause
accumulation of TDP-43 is not known, but it suggests a
role for p97/VCP in degradation of TDP-43 and/or for the
segregation of TDP-43 from the ribonucleoprotein particle
complexduringtranslation[228].Mutationsinp97/VCPcan
also cause familial ALS [231]. Very recently, p62 mutations
were reported in familial and sporadic ALS patients with
8-9 missense mutations predicted by in silico analyses as
candidate disease mutations [232].
8.3. Serpinopathies with ER Luminal Location. Similar to the
nucleus, the ER is a compartment lacking autophagosomes.
However, unlike nuclear aggregates that are not eﬃciently
degraded by autophagy [49], ER luminal aggregates can
be degraded by autophagy. Serpinopathies are a group of
diseasesassociatedwithaggregationofserpinfamilyproteins
in ER (reviewed in [233]). Serpins are inhibitors of extra-
and intracellular proteases, and they act as pseudosubstrates
that upon cleavage change conformation resulting in the for-
mation of an inactive serpin-protease complex. Functional
serpins are monomeric. In contrast, mutated variants are
associated with the formation of long and ordered polymers
causedbytheinsertionoftheﬂexibleandreactivecentreloop
of one molecule into a β-sheet of another. These aggregates
cannot be degraded by ERAD and accumulate inside the ER
lumen. Aggregation-prone and disease-causing mutant vari-
ants are known for several serpin family members, includ-
ing α1-antitrypsin, neuroserpin, α1-antichymotrypsin, C1-
inhibitor, and antithrombin.
The Z variant of α1-antitrypsin forms polymers that
accumulate in the ER of hepatocytes, and homozygosity for
this mutant allele causes the genetic disease α1-antitrypsin
deﬁciency. Since polymerization of serpin mutants occurs
posttranslation and most likely after complete folding of
the monomers [234], there is a window when monomers
can be degraded by ERAD. Hence, the Z-variant of α1-
antitrypsin is degraded by ERAD, but it also accumulates in
autophagosomes in liver cells of patients with α1-antitrypsin
deﬁciency and in cell culture [235, 236]. Its degradation is
reduced in autophagy deﬁcient cells, and this supports a
role for autophagy in degradation of mutated α1-antitrypsin
[235].
Another familial dementia is FENIB (Familial Enceph-
alopathy with Neuroserpin Inclusion Bodies) that is caused
by polymerization of mutant neuroserpin in ER of neurons.
Studies of mammalian cells and a Drosophila model ofInternational Journal of Cell Biology 13
serpinopathy revealed that ERAD and macroautophagy
cooperate also in degradation of mutant neuroserpin [234].
Autophagic degradation of polymeric neuroserpin and other
serpinopathies is probably coupled to autophagic degrada-
tion of ER itself. In this process, portions of ER are believed
to be engulfed along with proteins and protein aggregates.
It remains to be shown whether there exist mechanisms for
the speciﬁc delivery of serpin polymers to those regions of
ERthatundergodegradation.Noselectivitytowardsmutated
neuroserpin was observed for the autophagic degradation
of neuroserpin in neuronal-like PC12 cells, suggesting that
degradation of neuroserpin by autophagy is mainly a non-
selective bulk degradation process [234].
9. Concluding Remarks
Selective autophagy of protein aggregates has emerged as an
important protein quality control system in cells, and the last
decade has provided some major leaps in our understanding
of aggrephagy. The autophagy receptors p62 and NBR1
and the large adaptor protein ALFY play major roles in
aggrephagy. The level of ALFY in the brain is high [143], and
loss of ALFY or p62 is associated with neurodegeneration
[144, 155]. It is anticipated that more autophagy receptors
are involved in aggrephagy, and optineurin is one of them.
How much can be learned from studies of selective autopha-
gy of intracellular bacteria (xenophagy) that is also relevant
for aggrephagy? Novel autophagy receptors like NDP52 and
optineurin have emerged from studies of xenophagy, and
ubiquitination is heavily involved [26, 134]. Likely, also the
selective removal of damaged mitochondria (mitophagy)
may provide knowledge applicable to the understanding of
aggrephagy. For instance, p62 is involved in clustering of
mitochondria during mitophagy [237, 238].
As reﬂected in this paper, there is recent progress in the
understanding of the roles played by chaperones and their
cofactors in sorting of misfolded proteins to the diﬀerent
degradation pathways. Chaperones and co-chaperones, par-
ticularly BAG3, in addition to p97/VCP, HDAC6, TDP-43,
and ubiquilin-1, are important players in the formation of
aggregates, and they also aﬀect aggrephagy at several steps.
However, the study of autophagic degradation of protein
aggregates is still in its infancy in the sense that some
fundamental questions remain unanswered. For example, we
still do not know what size(s) of aggregates can be degraded
by selective autophagy. Is there an upper size limit? Is the
mosteﬃcientdegradationofalargeaggregateacombination
of UPS-, CMA-, and aggrephagy-mediated degradations? An
important role for chaperones and cofactors may then be to
orchestrate the diﬀerent degradative pathways and to help
to dissolve the aggregates. There is clearly some confusion
in the ﬁeld as to what are the similarities and diﬀerences
betweendiﬀerenttypesofproteinaggregatesdescribedinthe
literature. How should the diﬀerent types of aggregates and
protein inclusions be classiﬁed?
A central question is whether modulation of aggrepha-
gy is a relevant therapeutic strategy for neurodegenerative
diseases and other proteinopathies. There is a direct parallel
here to cancer where many clinical trials are under way to
test eﬀects of inhibiting or boosting autophagy as part of
treatment regimens for various cancers. It may very well be
that the broad preliminary conclusion is the same for can-
cer and neurodegenerative diseases; autophagy is generally
acting protectively before advanced disease, while it may be
harmful to stimulate autophagy in advanced disease states.
In cancer, successful tumor cells often depend on autophagy
(so inhibition is the best strategy), and in neurodegenerative
diseases there is often already a dysfunctional downstream
step so that stimulation of autophagosome formation may
not be beneﬁcial. The challenge is now to gain more
knowledge about the mechanisms involved in aggrephagy
and of the particular deﬁciencies in these mechanisms that
are decisive for onset and progression of neurodegenerative
diseases.
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